Silva Paul M 4
4 · Nurix Therapeutics, Inc. · Filed Oct 4, 2021
Insider Transaction Report
Form 4
Silva Paul M
Director
Transactions
- Award
Director Stock Option (right to buy)
2021-10-01+35,000→ 35,000 totalExercise: $31.24Exp: 2031-09-30→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/36 of the total shares monthly beginning November 1, 2021 until the option is fully vested on October 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.